Cover Page

Cite item


Innovation development of pharmaceutical industry is close connected to knowledge transfer going to each subsequent life cycle phase of medicinal product. Formal regulation of technology and knowledge transfer is essential for achievement high quality during production of medicines designed during development phase. Conceptual tools, approaches and requirements are considered that are necessary for knowledge and technology transfer across all the life cycle phases of medicines. They are based on scientific knowledge of medicinal products and take into account both international and Russian regulations in the area of development, production and distribution of medicines. Importance of taking into consideration all aspects related to quality of medicines in all steps of technology transfer is shown. An approach is described for technology transfer organization for Russian pharmaceutical manufacturers based on international guides in this area.


About the authors

V. V. Beregovykh

Sechenov First Moscow State Medical University, Russian Federation

Author for correspondence.
PhD, corresponding member of RAMS, Head of the Department of Industrial Pharmacy of SBEI HPE “I.M. Sechenov First Moscow State Medical University” of Ministry of Health, RAMS. Address: blng. 2, 8, Trubetskaya Street, Moscow, RF, 119991; tel.: +7 (495) 698-56-50 Russian Federation

O. R. Spitskii

OOO NNE Pharmaplan, Moscow, Russian Federation

Head of Quality System Department of “NNE Pharmaplan” LLC. Address: 19, Leninskaya Sloboda Street, Moscow, RF, 115280; tel.: +7 (499) 270-09-99 Russian Federation


  1. Sukhovei A.F., Golova I.M. Vestnik UrFU. Seriya: Ekonomika i upravlenie - Bulletin of Ural Federal University. Series: Economics and management. 2011; 3: 92–102.
  2. Titov V.V. Transfer tekhnologii (Transfer of Technologies). Available at:
  3. Kvashnina M.N. Vestnik Saratovskogo gosudarstvennogo tekhnicheskogo universiteta = Bylletin of Saratov State Technical University. 2008; 1: 190–194.
  4. Federal'nyi Zakon RF № 61-FZ ot 12 aprelya 2010 g. «Ob obrashchenii lekarstvennykh sredstv» [Federal Law RF № 61-FZ dated 12 April, 2010 “Circulation of Medicines”]. Moscow, 2010.
  5. ICH Q10. Pharmaceutical Quality System. ICH Harmonised Tripartite Guideline. 4 June 2008.
  6. ICH Q8(R2). Pharmaceutical Development. ICH Harmonised Tripartite Guideline. August 2009.
  7. ICH Q9. Quality Risk Management. ICH Harmonised Tripartite Guideline. 09 November 2005.
  8. Technology Transfer. Good Practice Guide. ISPE, 2003.
  9. WHO Guidelines on transfer of technology in pharmaceutical manufacturing. WHO Technical Report Series, No. 961, 2011.

Copyright (c) 1970 "Paediatrician" Publishers LLC

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies